Literature DB >> 9315653

Antagonism between Nur77 and glucocorticoid receptor for control of transcription.

A Philips1, M Maira, A Mullick, M Chamberland, S Lesage, P Hugo, J Drouin.   

Abstract

Two important functions of glucocorticoids (Gc), namely, suppression of immune system function and feedback repression of the hypothalamo-pituitary-adrenal (HPA) axis, are mediated through repression of gene transcription. Previous studies have indicated that this repression is exerted in part through antagonism between the glucocorticoid receptors (GR) and the AP-1 family of transcription factors. However, this mechanism could not account for repression of the pro-opiomelanocortin (POMC) gene, an important regulator of the HPA axis. Our recent identification of the orphan nuclear receptor Nur77 as a mediator of CRH induction of POMC transcription led us, in the present work, to show that Gc antagonize this positive signal at two levels. First, Gc partly blunt the CRH induction of Nur77 mRNA, and second, they antagonize Nur77-dependent transcription. GR repression is exerted by antagonism of Nur77 action on the NurRE element of the POMC gene. Gc antagonism of NurRE activity was observed in response to physiological stimuli in both endocrine (CRH induction of POMC) and lymphoid (T-cell receptor activation) cells. In transfection experiments, transcriptional activation by Nur77 and the repressor activity of liganded GR titrated each other on their cognate DNA target. In vitro binding experiments as well as mutation analysis of GR suggest that the mechanism of GR antagonism of Nur77 is very similar to that of the antagonism between GR and AP-1. The convergence of positive signals mediated by Nur77 (and also probably by related family members) and negative signals exerted by GR appears to be a general mechanism for control of transcription, since it is active in both endocrine and lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9315653      PMCID: PMC232443          DOI: 10.1128/MCB.17.10.5952

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells.

Authors:  A Philips; S Lesage; R Gingras; M H Maira; Y Gauthier; P Hugo; J Drouin
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors.

Authors:  E P Murphy; O M Conneely
Journal:  Mol Endocrinol       Date:  1997-01

3.  A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression.

Authors:  T Heinzel; R M Lavinsky; T M Mullen; M Söderstrom; C D Laherty; J Torchia; W M Yang; G Brard; S D Ngo; J R Davie; E Seto; R N Eisenman; D W Rose; C K Glass; M G Rosenfeld
Journal:  Nature       Date:  1997-05-01       Impact factor: 49.962

4.  Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase.

Authors:  L Nagy; H Y Kao; D Chakravarti; R J Lin; C A Hassig; D E Ayer; S L Schreiber; R M Evans
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

5.  Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis.

Authors:  L E Cheng; F K Chan; D Cado; A Winoto
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

6.  Homodimer formation is rate-limiting for high affinity DNA binding by glucocorticoid receptor.

Authors:  J Drouin; Y L Sun; S Tremblay; P Lavender; T J Schmidt; A de Léan; M Nemer
Journal:  Mol Endocrinol       Date:  1992-08

7.  Cell-specific helix-loop-helix factor required for pituitary expression of the pro-opiomelanocortin gene.

Authors:  M Therrien; J Drouin
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

8.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

9.  Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo.

Authors:  H König; H Ponta; H J Rahmsdorf; P Herrlich
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

10.  Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene.

Authors:  J Drouin; Y L Sun; M Chamberland; Y Gauthier; A De Léan; M Nemer; T J Schmidt
Journal:  EMBO J       Date:  1993-01       Impact factor: 11.598

View more
  53 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  Tbx19, a tissue-selective regulator of POMC gene expression.

Authors:  J Liu; C Lin; A Gleiberman; K A Ohgi; T Herman; H P Huang; M J Tsai; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease.

Authors:  Mathias Riebold; Christian Kozany; Lee Freiburger; Michael Sattler; Michael Buchfelder; Felix Hausch; Günter K Stalla; Marcelo Paez-Pereda
Journal:  Nat Med       Date:  2015-02-09       Impact factor: 53.440

4.  Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells.

Authors:  A Philips; S Lesage; R Gingras; M H Maira; Y Gauthier; P Hugo; J Drouin
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  Recruitment of octamer transcription factors to DNA by glucocorticoid receptor.

Authors:  G G Préfontaine; M E Lemieux; W Giffin; C Schild-Poulter; L Pope; E LaCasse; P Walker; R J Haché
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 6.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

7.  Retinoic acid prevents experimental Cushing syndrome.

Authors:  M Páez-Pereda; D Kovalovsky; U Hopfner; M Theodoropoulou; U Pagotto; E Uhl; M Losa; J Stalla; Y Grübler; C Missale; E Arzt; G K Stalla
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  Nr4a1 is required for fasting-induced down-regulation of Pparγ2 in white adipose tissue.

Authors:  Kalina Duszka; Juliane G Bogner-Strauss; Hubert Hackl; Dietmar Rieder; Claudia Neuhold; Andreas Prokesch; Zlatko Trajanoski; Anne-M Krogsdam
Journal:  Mol Endocrinol       Date:  2012-12-18

9.  Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin.

Authors:  Pierre-Luc Lavoie; Lionel Budry; Aurélio Balsalobre; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2008-04-03

10.  Altered transcription factor trafficking in oxidatively-stressed neuronal cells.

Authors:  Vivek P Patel; Donald B Defranco; Charleen T Chu
Journal:  Biochim Biophys Acta       Date:  2012-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.